W Dalton Dietrich

This inventor holds 9 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Miami, Tetra Discovery Partners, LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: W Dalton Dietrich. Retrieved from https://idiyas.com/inventor/w-dalton-dietrich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 12)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 15(Granted Patents)

Company Filing History:

Tetra Discovery Partners, LLC

patents

Years Active: 2014-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570735 - COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME RELATED DISEASES OR CONDITIONS (2026-03-10),

2. 12560618 - INNATE IMMUNE PROTEINS AS BIOMARKERS FOR CNS INJURY (2026-02-24),

3. 11840565 - Methods and compositions for treating virus-associated inflammation (2023-12-12),

4. 11174307 - Methods and compositions for treating virus-associated inflammation (2021-11-16),

5. 10961306 - Methods for treating lung inflammation with an anti-ASC antibody (2021-03-30),

6. 10703811 - Methods and compositions for treating multiple sclerosis (2020-07-07),

7. 9512209 - Methods of modulating inflammasome activity to treat inflammatory conditions (2016-12-06),

8. 8865723 - Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury (2014-10-21),

9. 8685400 - Modulating inflammasome activity and inflammation in the central nervous system (2014-04-01),

Title: W Dalton Dietrich: Innovator in Virus-Associated Inflammation Treatment

Introduction

W Dalton Dietrich is a prominent inventor based in Miami, FL, known for his significant contributions to medical research and innovation. With a total of seven patents to his name, Dietrich has made strides in developing methods and compositions aimed at treating virus-associated inflammation, including those linked to critical respiratory conditions.

Latest Patents

Among his latest patents are groundbreaking methods and compositions for treating virus-associated inflammation. These innovations include agents that inhibit inflammasome signaling in mammals, utilizing antibodies directed against inflammasome components. These treatments are particularly relevant in managing lung inflammation associated with viral infections, specifically SARS-CoV-2. The detailed methodologies and agents described in these patents highlight their potential utility in clinical applications and therapeutic settings.

Career Highlights

Throughout his career, W Dalton Dietrich has worked with esteemed organizations, including the University of Miami and Tetra Discovery Partners, LLC. His work has focused on leveraging scientific knowledge to create effective interventions for inflammatory responses caused by viral infections, showcasing his commitment to advancing health care solutions.

Collaborations

Dietrich has engaged in collaborations with notable colleagues, including Robert W Keane and Juan Pablo De Rivero Vaccari. These partnerships underscore the importance of teamwork and collective expertise in tackling complex medical challenges, further enriching the field of biomedical research.

Conclusion

W Dalton Dietrich exemplifies the spirit of innovation in the medical field, particularly in addressing the challenges posed by virus-associated inflammation. His research and patents not only contribute to scientific advancement but also offer hope for improved treatment options for patients affected by these conditions. With his ongoing efforts, dietrich continues to pave the way for future innovations that may enhance therapeutic strategies in healthcare.

Profile summary based on public USPTO records.